Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657655 · ClinicalTrials.gov registry record · NA
Kinesia 360 Parkinson's Monitoring Study
A NA study, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02657655 is a NA study that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 45 participants.
The verdict
NCT02657655, a NA study, has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.
Interventions
- DEVICE Kinesia 360
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657655
The ClinicalTrials.gov registry entry for NCT02657655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kinesia 360 is the first listed.
NCT02657655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657655 about?
NCT02657655 is a clinical study titled "Kinesia 360 Parkinson's Monitoring Study". Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.
What is the current status of trial NCT02657655?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-01. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02657655?
The interventions under investigation include: Kinesia 360 (DEVICE).
Who is sponsoring clinical trial NCT02657655?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.